Researcher.Life Logo

Expert Opinion on Drug Delivery : Impact Factor & More

eISSN: 1744-7593pISSN: 1742-5247

Aims and Scope of Expert Opinion on Drug Delivery

Expert Opinion on Drug Delivery is a monthly peer-reviewed medical journal publishing review articles covering all aspects of research on drug delivery, from initial concept to potential therapeutic application and final relevance in clinical use. It was established in 2004 and is published by Taylor and Francis Group. The editor-in-chief is Uday Kompella (University of Colorado). Less

Key Metrics

CiteScore
10.4
Eigenfactor
0.005 - 0.01
Impact Factor
5 - 10
SJR
Q1Pharmaceutical Science
SNIP
1.34
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Expert Opinion on Drug Delivery

Expert Opinion on Drug Delivery Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher TAYLOR & FRANCIS LTD
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year2004
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Expert Opinion on Drug Delivery ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Expert Opinion on Drug Delivery

An overview of targeted drug delivery systems specific for fibroblast growth factor receptors and their co-receptors
  • 3 Aug 2026
  • Expert Opinion on Drug Delivery
Quality by design in advanced anticancer therapeutics: bridging design space, manufacturing, and clinical performance.
  • 19 May 2026
  • Expert opinion on drug delivery
Targeting the brain: alternative administration routes and drug delivery systems for antidepressant therapy
  • 14 May 2026
  • Expert Opinion on Drug Delivery
Immunomodulatory strategies and targeted delivery systems in atherosclerosis therapy
  • 8 May 2026
  • Expert Opinion on Drug Delivery
Advancing transdermal drug delivery: integration of microneedle technology and iontophoresis for enhanced therapeutic outcomes
  • 8 May 2026
  • Expert Opinion on Drug Delivery
Mechanistic and translational frontiers on “VEGF and TKI inhibitor axitinib”: unfolding drug delivery approaches and opportunities in cancer therapy
  • 4 May 2026
  • Expert Opinion on Drug Delivery
An overview of targeted drug delivery systems specific for fibroblast growth factor receptors and their co-receptors
  • 3 Aug 2026
  • Expert Opinion on Drug Delivery
Quality by design in advanced anticancer therapeutics: bridging design space, manufacturing, and clinical performance.
  • 19 May 2026
  • Expert opinion on drug delivery
Targeting the brain: alternative administration routes and drug delivery systems for antidepressant therapy
  • 14 May 2026
  • Expert Opinion on Drug Delivery
Immunomodulatory strategies and targeted delivery systems in atherosclerosis therapy
  • 8 May 2026
  • Expert Opinion on Drug Delivery
Advancing transdermal drug delivery: integration of microneedle technology and iontophoresis for enhanced therapeutic outcomes
  • 8 May 2026
  • Expert Opinion on Drug Delivery
Mechanistic and translational frontiers on “VEGF and TKI inhibitor axitinib”: unfolding drug delivery approaches and opportunities in cancer therapy
  • 4 May 2026
  • Expert Opinion on Drug Delivery

FAQs on Expert Opinion on Drug Delivery